Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Prevention of mother-to-child transmission news

Show

From To
New guidelines recommend that women avoid tenofovir & emtricitabine during pregnancy

Women should be offered the choice to avoid treatment with tenofovir and emtricitabine during pregnancy owing to a higher risk of stillbirth and early infant

Published
13 September 2017
By
Keith Alcorn
Alice Welbourn: WHO and the rights of women living with HIV

A recent set of articles on HIV in pregnancy, published by The BMJ and BMJ Open, raises concerns that some combination anti-retroviral therapies (cARTs) may harm babies. This highlights the need for changes to current WHO practice towards pregnant women living with HIV, which is no doubt well-intentioned but ill thought-out.

Published
12 September 2017
From
BMJ Opinion
New recommendations aim to help pregnant women with HIV make informed choices

New recommendations on antiretroviral drugs for pregnant women living with HIV can help women make more informed choices about benefits and harms, say a panel of international experts in The BMJ today. The panel recommend older drug combinations instead of the most widely used regimens to help reduce the risk of premature birth and neonatal death - which almost all women said they were extremely keen to avoid.

Published
12 September 2017
From
EurekAlert
Adolescents with HIV do better in more prosperous African countries, even with treatment

Adolescents who acquired HIV perinatally were less likely to die, grew faster and had better immune restoration on treatment if they lived in upper-middle income

Published
31 July 2017
By
Carole Leach-Lemens
Vertical HIV transmission may be influenced by complex synergies with other STI – such as Cytomegalovirus

The apparently greater susceptibility of sub-Saharan African women to HIV infection has led researchers to consider the various potential synergies between HIV and other genital infections or conditions of the vaginal microbiome. A recent study brings this wider perspective to bear on mother-to-child transmission, casting some fresh light on the complex interrelation between the ‘vertical’ transmission of HIV and active and Cytomegalovirus (CMV) viruria.

Published
27 July 2017
From
BMJ Group blogs
Integrase inhibitors not causing higher rates of adverse birth outcomes, Botswana and French studies show

Dolutegravir-based antiretroviral therapy (ART) started in pregnancy is as safe as efavirenz-based ART, according to a study of birth outcomes at eight maternity wards throughout Botswana accounting for

Published
25 July 2017
By
Carole Leach-Lemens
Why are women lost from HIV care during pregnancy? Malawi study shows social support and counselling are critical

Lack of social support after diagnosis and inadequate counselling about HIV treatment and HIV disclosure were identified as key reasons for dropping out of HIV

Published
28 June 2017
By
Keith Alcorn
HIV drug resistance becoming more common in Zambian infants

The proportion of infants with HIV who had drug resistance at the time of HIV diagnosis almost doubled in Zambia between 2009 and 2014 despite

Published
27 June 2017
By
Keith Alcorn
Malawi: Study finds fear drives pregnant women with HIV from prevention services

Our study investigated why HIV-positive pregnant women might drop out of an Option B+ treatment program. For many, the answer was fear. Fear of HIV disclosure, fear of stigma, fear of their husband’s reaction, risk of divorce and loss of economic support, along with a lack of social support, lack of self-efficacy and agency for women in the culture, and a lack of male involvement in the program generally.

Published
26 June 2017
From
Science Speaks
Meds May Impact Prenatal Screening in HIV+ Patients

Pregnant women with HIV taking integrase inhibitors at the time of their non-invasive prenatal screening test had a lower mean fetal fraction than those who were not taking the medication, a small study found here.

Published
08 June 2017
From
MedPage Today HIV/AIDS
← First12345...38Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.